Navigating the New Normal: Pharmacovigilance and Regulatory Trends in the UK (2026)
In the world of life sciences, the UK has always been a titan. However, as we move through 2026, the “Standard Operating Procedure” has changed. With the full implementation of the Windsor Framework and recent updates to pharmacovigilance regulations, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is carving a path that is both independent of and...
0 Комментарии 0 Поделились